Background: Obesity, the condition of excessive accumulation of fat is a poorly understood disorder and is a risk factor for type II diabetes, hypertension, and hyperlipidaemia. Recently, a putative mouse obese gene was cloned and its product, termed ob protein, was shown to be involved in the regulation of body weight. Materials and Methods: Bacterial and insect cells were used for expression of recombinant mouse ob protein.
INTRODUCTION
Obesity is a complex disorder that is poorly understood and is a risk factor for hyperglycemia, hypothermia, and hyperinsulimea (1, 2) . Appetite, energy balance, and body weight gain are modulated by diverse neurochemical and neuroendocrine signals from different organs in the body and specific regions of the brain (3, 4) . In particular, changes in food intake were observed after direct administration of specific drugs in the hypothalamus, suggesting a key role of this organ in satiety and energy balance (5) (6) (7) . This is supported by the findings that abnormalities or introduced lesions in the hypothalamus resulted molecule, the mature form of which was found in mouse serum. Biochemical analysis identified the processing site in the ob precursor molecule and an intramolecular disulfide bond in the mature form that is necessary for activity. Reduction of food intake and weight gain after administration of ob protein to genetically obese mice and wild-type rats is reversible. Discussion: This study demonstrates that ob protein is a secreted satiety factor which regulates body weight and reduces food intake even in animals with no genetic body weight abnormalities. The failure of ob protein to effect these parameters in db/db mice supports the hypothesis that these mice are deficient in a signaling molecule that normally responds to the ob protein.
in an obese phenotype (7) . Up until now, the identity of specific proteins/factors involved in the regulation of body weight balance was unknown.
Genetic analyses have identified six single gene mutations associated with an obese phenotype (8) (9) (10) (11) . Two of these mutations, termed obese (ob) and diabetes (db), have been studied in detail (reviewed in Refs. 2 and 12) . Syndromes associated with these mutations resemble conditions of morbid obesity in humans (9, 10) . Experiments in which wild-type and obese animals were surgically joined (parabiosis), suggested that ob/ob mice lack a satiety hormone which regulates food consumption and weight gain, whereas db/db mice may lack downstream signaling function (8, 13) . Recently, a putative mouse obese gene was isolated and the mRNA was detected exclusively in fat tissues (10) . The gene product, termed ob protein ("leptin"), was shown to be involved in the regulation of body weight (14) (15) (16) . Here, we extended these studies by the identification and characterization of the active form of ob protein. We determined the processing site in the ob precursor molecule and provide evidence for a specific secondary structure in the mature form that is required for biological activity. Moreover, we show that reduction of food intake and weight gain after administration of ob protein to genetically obese mice and wild-type rats is reversible.
MATERIALS AND METHODS

Cloning of Mouse ob Protein
Coding region for mouse ob protein was obtained by reverse transcriptase-polymerase chain reaction (RT-PCR) according to the manufacturers conditions (Pharmacia, Piscataway, NJ) using polyA(+) mRNA isolated from adipose tissue, reverse primer 5'-GCGGATCCTCAGCATTCAGGGCT AACATCCAACT-3' and forward primer 5'-CGCATATGTGCTGGAGACCCCTGT-3', based on the published sequence (10) . Sequences in italics represent nucleotides of the coding and noncoding strand which were extended either at the 5' or 3' end with nucleotides to create restriction enzyme sites. ob (22-167) was PCR amplified using mouse ob cDNA as template, forward primer 5'-GCTCTAGACATATGGTGCCTATCCAGA A A G TCC-3', including an initiation codon for translation in bacteria, and the above-mentioned reverse primer. ob-C167A was PCR amplified as described above using reverse primer 5'-CGCGG ATC CTCACGCTTCAGGGCTAACATCCAACTG -3'. The fidelity of the PCR-amplified ob coding regions was verified by DNA sequencing.
Expression and Purification of Recombinant ob Protein and Immunoblot Analysis Escherichia coli K12 strain BL21 (DE3)plys (17) was used for bacterial ob protein expression in plasmid pET ( 17) . Plasmids pEVRF (18) was used for ob protein expression in COS-7 cells. Transient DNA transfections into mammalian cells were performed as described (19) . ob protein expressed in bacteria at a level of 500 mg/l was isolated from inclusion bodies as follows: bacterial cells were disrupted by French Press in phosphate-buffered saline (PBS), pH 7.5, supplemented with 1 mM EDTA (lysis buffer), and inclusion bodies washed with lysis buffer plus 1% Triton X-100. ob protein was solubilized in 20 mM Tris-HCl (pH 7.5), 10 mM NaCl, 7 M urea and chromatographed on a Q-Sepharose fast flow column (Pharmacia). The ob protein was eluted with an NaCl gradient, adjusted to 0.2 mg/ml, and dialyzed against PBS (containing 0.1 g/l Ca/Mg) overnight. Plasmid PAcC13 (20) was used for expression of ob protein in SF9 insect cells (21, 22 We designed experiments to determine if our purified ob protein represents the proposed blood-borne factor that regulates food intake and eating behavior (8, 13) . To this end, we administered purified recombinant mature ob protein into ob/ob animals, which lack this protein and are obese (Fig. 2) . Intraperitoneal injection of 3 mg/kg/day showed a significant reduction in weight gain of 65% compared to control obese animals injected with saline (p value: >0.01) (Fig. 2 A and C) . After completion of the ob regimen, weight gain increased and was even higher (47%) than that of control animals ( Fig. 2 A and C) . These data indicate that the administration of ob protein induced a significant reduction in weight gain and, importantly, that the effect of ob protein is reversible. Administration of ob protein to db/db animals had no effect, suggesting that these animals lack a signaling molecule that normally responds to ob protein ( Fig. 2 B and D) . The lack of response to ob protein in db/db mice also testifies to the purity of the protein preparation, since toxic contaminants could theoretically be responsible for the observed reduction in weight gain in the ob/ob mice.
To examine whether appetite suppression induced by recombinant mouse ob protein would only be detected in obese animals, we administered ob protein into wild-type rats. Intravenous delivery of ob protein at a dose of 0.3 mg/kg into wild-type rats also resulted in weight loss and reduction in food intake (Fig. 3) . In injected animals almost no weight gain was detected during the 5-day period in the rats treated with recombinant ob protein compared with control rats administered with saline ( Fig. 3 A and B) . Food intake in the treated group was 30% lower than that of the control group (Fig. 3C) . As with ob/ob mice, cessation of the injections resulted in weight gain that was indistinguishable from the control group (Fig. 3B) .
In the course of these experiments we noticed a difference in the activities of recombinant ob protein purified from bacteria and that from insect cell supernatant. Administration of purified ob protein from insect cell supernatant at a dose of 0.3 and 3.0 mg/kg to obese and wild-type animals was more effective than bacterially expressed ob protein (Table 1 and data not shown). Treated ob/ob mice gained only 18 or 31% of the weight of control animals when injected with 3.0 mg/kg ob protein purified from insect cell supernatant or bacteria, respectively. Less pronounced effects on weight gain were detected using 0.3 mg/kg, indicating a dose-dependent function of this protein in obesity.
The presence of two cysteine residues in the ob primary structure raised the question of whether these amino acids might be involved in the formation of a specific secondary structure. Analysis of recombinant wild-type ob proteins by nonreducing SDS-PAGE showed a significantly faster mobility in the absence of reducing agent (Fig. 4) . This increase in the mobility is characteristic of the presence of an intramolecular disulfide bond (26) . To examine whether the formation of the loop structure at the C terminus of ob protein is important for biological activity, we performed site-directed mutagenesis to change the cysteine at amino acid 167 to alanine. No change in the migration of this mutant ob protein, ob-C 1 67A, was detected when analyzed by SDS-PAGE in the absence of reducing agent compared with the wild-type protein, indicating the absence of the intramolecular disulfide bond (Fig. 4) . However, the mutant ob protein was able to form dimers (data not shown). Administration of ob-C 1 67A protein at a concentration of 3 mg/kg to ob/ob mice showed almost no effect in the regulation of weight gain compared with the same amount of wild-type protein (Fig. 5) . Thus, these data suggest that biologically active ob protein comprises an intramolecular disulfide bond which results in a loop at the C terminus consisting of 51 amino acids, and is necessary for activity.
DISCUSSION
Our findings have identified the biologically active form of ob protein and characterized its role in the regulation of food intake and body weight gain. Our data are consistent with recent reports which have shown that daily injections of recombinant ob protein into ob/ob mice lowered body weight, percentage body fat, and food intake (14) (15) (16) . Administration of ob protein to wild-type mice showed only a weak effect on body weight gain (14, 15) . Wild-type rats injected with ob protein, however, showed almost no weight gain compared with control animals (Fig. 3) . One interpretation of this result is that wild-type rats are more sensitive to ob protein than wild-type mice. A different explanation might consider the method of administration. In the mice studies (14, 15) , ob protein was administered intraperitoneally, whereas wild-type rats were injected intravenously (Fig. 3) . Although both routes showed in our hands an immediate effect on the amount of weight gain and food intake (compare Figs. 2A and 3) , an analysis of the pharmakokinetics of ob protein will be necessary to distinguish between the two possibilities.
The observed difference in the activity between ob protein purified from insect cells and bacteria is most likely the result of the purification protocol used. Bacterially expressed ob protein was isolated from inclusion bodies and had to be refolded, whereas ob protein purified from insect cell supernatant was soluble. Although we did not detect significant differences between both proteins in SDS-PAGE, we cannot rule out that the presence of an extra methionine residue in the bacterially expressed ob protein is responsible for the reduced activity.
Another important observation of our study is that the effect of ob protein on eating behavior is reversible. After cessation of the ob regimen, treated mice rapidly gained weight (Fig. 2 A  and C) . Weight gain was even higher in the treated group than in the control animals. Similar results were observed with wild-type rats. Shortly after the last injection of ob protein, weight gain of treated rats were indistinguishable from control animals (Fig. 3) Groups of five ob/ob mice were administered daily with saline or ob protein at different concentrations.
aChange in body weight in grams between control and treated animals at Day 10 was significantly different (P < 0.01) as determined by a nonparametric Wilcoxon test (unpaired; two-tailed).
tions of ob protein in treating obesity, especially with respect to the duration of treatment and in light of a possible desensitization of the ob receptor. Our data confirm that ob protein functions as a satiety factor, and support previous observations with parabiosed animals (8, 13) . In these experiments, normal mice were joined surgically with ob/ob mice, and the obese animal lost weight, suggesting the presence of a soluble factor in serum of wild-type animal. The previous reports, as well as the data presented here, are highly suggestive that this soluble factor is ob. These data also give an explanation as to why ob/ob mice starved to death when surgically joined to db/db mice (8) . As (Fig.  1C) . Moreover, we identified that biologically active ob protein consists of an intramolecular disulfide bond which results in the formation of a loop structure at the C terminus. A mutant form of ob protein, ob-C167A, in which the Cterminal cysteine was substituted with alanine to prevent formation of this loop structure, showed no effect on food intake and weight gain when injected into obese animals (Fig. 5 ). Whether this loop structure is necessary for the interaction with a putative ob receptor or is involved in stabilization of the mature protein has to be determined. Identification of the ob receptor and characterization of ob gene regulation should help define the molecular pathways that regulate satiety and metabolic changes in the obese state.
